Publikationen - Institut für Radiopharmazeutische Krebsforschung - Jahr 2024
4 Publikationen2024
64Cu tumor labeling with hexadentate picolinic acid-based bispidine immunoconjugates
Kubeil, M.; Neuber, C.; Starke, M.; Arndt, C.; Rodrigues Loureiro, L. R.; et al. (11 authors)
-
Chemistry - A European Journal (2024)
DOI: 10.1002/chem.202400366
Impact of Viscosity on Human Hepatoma Spheroids in Soft Core-Shell Microcapsules
Peng, X.; Janićijević, Ž.; Lemm, S.; Hauser, S.; Knobel, M.; et al. (8 authors)
-
Advanced Healthcare Materials (2024), 2302609
DOI: 10.1002/adhm.202302609
Preclinical evaluation of an ¹⁸F-labeled Nε-acryloyllysine piperazide for covalent targeting of transglutaminase 2
Wodtke, R.; Laube, M.; Hauser, S.; Meister, S.; Ludwig, F.-A.; et al. (9 authors)
-
EJNMMI Radiopharmacy and Chemistry 9(2024)1, 1
DOI: 10.1186/s41181‑023‑00231‑1
Improving susceptibility of neuroendocrine tumors to radionuclide therapies: personalized approaches towards complementary treatments
Richter, S.; Steenblock, C.; Lemm, S.; Ziegler, C. G.; Bechmann, N.; et al. (8 authors)
-
Theranostics 14(2024)1, 17-32
DOI: 10.7150/thno.87345
Jahre: 2024 2023 2022 2021 2020
